These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15596512)

  • 41. Formation of three-dimensional structures in supported lipid bilayers.
    Cambrea LR; Hovis JS
    Biophys J; 2007 May; 92(10):3587-94. PubMed ID: 17325003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of cholesterol on voids in phospholipid membranes.
    Falck E; Patra M; Karttunen M; Hyvönen MT; Vattulainen I
    J Chem Phys; 2004 Dec; 121(24):12676-89. PubMed ID: 15606294
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EPR investigation of clomipramine interaction with phosphatidylcholine membranes in presence and absence of cholesterol.
    Yonar D; Paktaş DD; Horasan N; Strancar J; Sentjurc M; Sünnetçioğlu MM
    J Liposome Res; 2011 Sep; 21(3):194-202. PubMed ID: 20624028
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fluorescence correlation studies of lipid domains in model membranes.
    Kahya N; Schwille P
    Mol Membr Biol; 2006; 23(1):29-39. PubMed ID: 16611578
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of the behavior of cholesterol and selected derivatives in mixed sterol-phospholipid Langmuir monolayers: a fluorescence microscopy study.
    Berring EE; Borrenpohl K; Fliesler SJ; Serfis AB
    Chem Phys Lipids; 2005 Jul; 136(1):1-12. PubMed ID: 15904906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Concurrent Compression of Phospholipid Membranes by Calcium and Cholesterol.
    Melcrová A; Pokorna S; Vošahlíková M; Sýkora J; Svoboda P; Hof M; Cwiklik L; Jurkiewicz P
    Langmuir; 2019 Sep; 35(35):11358-11368. PubMed ID: 31393734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative behavior of sterols in phosphatidylcholine-sterol monolayer films.
    Serfis AB; Brancato S; Fliesler SJ
    Biochim Biophys Acta; 2001 Apr; 1511(2):341-8. PubMed ID: 11286977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Developmental changes in synaptic membrane lipid composition and fluidity.
    Hitzemann RJ; Johnson DA
    Neurochem Res; 1983 Feb; 8(2):121-31. PubMed ID: 6856021
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differences in the modulation of collective membrane motions by ergosterol, lanosterol, and cholesterol: a dynamic light scattering study.
    Hildenbrand MF; Bayerl TM
    Biophys J; 2005 May; 88(5):3360-7. PubMed ID: 15764657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cholesterol, lanosterol, and ergosterol attenuate the membrane association of LL-37(W27F) and temporin L.
    Sood R; Kinnunen PK
    Biochim Biophys Acta; 2008 Jun; 1778(6):1460-6. PubMed ID: 18358828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of resveratrol on the structure and fluidity of lipid bilayers: a membrane biophysical study.
    Neves AR; Nunes C; Amenitsch H; Reis S
    Soft Matter; 2016 Feb; 12(7):2118-26. PubMed ID: 26745787
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nonenzymatic biomimetic remodeling of phospholipids in synthetic liposomes.
    Brea RJ; Rudd AK; Devaraj NK
    Proc Natl Acad Sci U S A; 2016 Aug; 113(31):8589-94. PubMed ID: 27439858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Imaging fast SNARE mediated-membrane fusion in planar-supported bilayers.
    Kiessling V
    Biophys J; 2005 Oct; 89(4):2185-6. PubMed ID: 16100260
    [No Abstract]   [Full Text] [Related]  

  • 54. Desmosterol replaces cholesterol for ligand binding function of the serotonin(1A) receptor in solubilized hippocampal membranes: support for nonannular binding sites for cholesterol?
    Singh P; Jafurulla M; Paila YD; Chattopadhyay A
    Biochim Biophys Acta; 2011 Oct; 1808(10):2428-34. PubMed ID: 21763272
    [TBL] [Abstract][Full Text] [Related]  

  • 55. First synthesis of ent-desmosterol and its conversion to ent-deuterocholesterol.
    Westover EJ; Covey DF
    Steroids; 2003 Feb; 68(2):159-66. PubMed ID: 12606007
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The structural role of cholesterol in biological membranes.
    Sugahara M; Uragami M; Yan X; Regen SL
    J Am Chem Soc; 2001 Aug; 123(32):7939-40. PubMed ID: 11493081
    [No Abstract]   [Full Text] [Related]  

  • 57. How to stabilize phospholipid liposomes (using nanoparticles).
    Zhang L; Granick S
    Nano Lett; 2006 Apr; 6(4):694-8. PubMed ID: 16608266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of cholesterol and model transmembrane proteins on drug partitioning into lipid bilayers as analysed by immobilized-liposome chromatography.
    Lagerquist C; Beigi F; Karlén A; Lennernäs H; Lundahl P
    J Pharm Pharmacol; 2001 Nov; 53(11):1477-87. PubMed ID: 11732750
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro determination of the solubility limit of cholesterol in phospholipid bilayers.
    Epand RM; Bach D; Wachtel E
    Chem Phys Lipids; 2016 Sep; 199():3-10. PubMed ID: 27370110
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Interaction of F-actin with artificial phospholipid membranes].
    Grigor'ev PA; Tarakhovskiĭ IuS; Pavlik LL; Mukhtasimova NF; Udal'tsov SN; Moshkov DA; Ivanitskiĭ GR
    Dokl Akad Nauk; 1999 Jun; 366(5):695-8. PubMed ID: 10439920
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.